Cytokinetics (CYTK) Debt/Equity Ratio: History & Chart

Cytokinetics, Incorporated(CYTK)

Biotechnology · South San Francisco, CA

$61.88-0.82 (-1.30%)

Delayed quote: Oct 6, 2026, 11:55 AM EDT

About Cytokinetics, Incorporated

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

South San Francisco, CA

673 employees

www.cytokinetics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Robert I. Blum

View full financials

CYTK Debt to Equity Ratio Metrics

DEBT TO EQUITY RATIO

-7.32

DEBT TO EQUITY RATIO AVG TTM

-3.09

DEBT TO EQUITY RATIO AVG 3Y

-2.10

DEBT TO EQUITY RATIO AVG 5Y

-1.51

DEBT TO EQUITY RATIO AVG 10Y

-0.91

DEBT TO EQUITY RATIO AVG 15Y

-0.20

DEBT TO EQUITY RATIO AVG 20Y

0.11

CURRENT VS TTM AVG

-136.96%

CURRENT VS 3Y AVG

-248.45%

CURRENT VS 5Y AVG

-385.37%

CURRENT VS 10Y AVG

-701.55%

CURRENT VS 15Y AVG

-3553.37%

CURRENT VS 20Y AVG

-7037.28%

SECTOR MEDIAN · HEALTHCARE

0.13

median of 633 covered companies

CURRENT VS SECTOR MEDIAN

-5733.56%

vs the sector median at left

NAME	MARKET CAP	DEBT TO EQUITY RATIO	TTM	3Y	5Y
Cytokinetics, Incorporated (CYTK)	$7.70B	-7.32	-3.09	-2.10	-1.51
HealthEquity, Inc. (HQY)vs ›	$7.66B	0.49	0.50	0.49	0.55
Hinge Health, Inc. (HNGE)vs ›	$7.58B	0.02	0.03	0.03	0.03
Praxis Precision Medicines, Inc. (PRAX)vs ›	$7.84B	0.00	0.00	0.02	0.02
Ionis Pharmaceuticals, Inc. (IONS)vs ›	$7.39B	5.50	3.88	3.48	2.79
Caris Life Sciences, Inc. (CAI)vs ›	$8.11B	0.76	0.66	0.66	1.58
Alkermes plc (ALKS)vs ›	$7.08B	0.87	0.04	0.19	0.25
Oscar Health, Inc. (OSCR)vs ›	$8.41B	0.21	0.37	0.36	0.29
Kymera Therapeutics, Inc. (KYMR)vs ›	$8.67B	0.05	0.08	0.10	0.09
Immunovant, Inc. (IMVT)vs ›	$6.66B	0.00	0.00	0.00	0.00

NAME

MARKET CAP

DEBT TO EQUITY RATIO

TTM

Cytokinetics, Incorporated (CYTK)

$7.70B

-7.32

-3.09

-2.10

-1.51

HealthEquity, Inc. (HQY)vs ›

$7.66B

0.49

0.50

0.49

0.55

Hinge Health, Inc. (HNGE)vs ›

$7.58B

0.02

0.03

Praxis Precision Medicines, Inc. (PRAX)vs ›

$7.84B

0.00

0.02

Ionis Pharmaceuticals, Inc. (IONS)vs ›

$7.39B

5.50

3.88

3.48

2.79

Caris Life Sciences, Inc. (CAI)vs ›

$8.11B

0.76

0.66

1.58

Alkermes plc (ALKS)vs ›

$7.08B

0.87

0.04

0.19

0.25

Oscar Health, Inc. (OSCR)vs ›

$8.41B

0.21

0.37

0.36

0.29

Kymera Therapeutics, Inc. (KYMR)vs ›

$8.67B

0.05

0.08

0.10

0.09

Immunovant, Inc. (IMVT)vs ›

$6.66B

0.00

Debt to Equity Ratio FAQ

What is the debt to equity ratio for Cytokinetics, Incorporated (CYTK)?

The debt to equity ratio for CYTK stock is -7.32.

Is Cytokinetics, Incorporated's debt to equity ratio high or low?

The debt to equity ratio of -7.32 is 385% below its 5-year average of -1.51, around the middle of its 5-year range (-56.76–15.20).

What is the TTM average debt to equity ratio for Cytokinetics, Incorporated (CYTK)?

The TTM average debt to equity ratio for CYTK stock is -3.09.

What is the 3Y average debt to equity ratio for Cytokinetics, Incorporated (CYTK)?

The 3Y average debt to equity ratio for CYTK stock is -2.10.

What is the 5Y average debt to equity ratio for Cytokinetics, Incorporated (CYTK)?

The 5Y average debt to equity ratio for CYTK stock is -1.51.

What is the 10Y average debt to equity ratio for Cytokinetics, Incorporated (CYTK)?

The 10Y average debt to equity ratio for CYTK stock is -0.91.

What is the 15Y average debt to equity ratio for Cytokinetics, Incorporated (CYTK)?

The 15Y average debt to equity ratio for CYTK stock is -0.20.

What is the 20Y average debt to equity ratio for Cytokinetics, Incorporated (CYTK)?

The 20Y average debt to equity ratio for CYTK stock is 0.11.

DATE	DEBT TO EQUITY RATIO
2026-06-30	-7.32
2026-03-31	-1.56
2025-12-31	-1.95
2025-09-30	-2.30
2025-06-30	-2.33
2025-03-31	-2.97
2024-12-31	-5.83
2024-09-30	-56.76
2024-06-30	7.28
2024-03-31	-1.91
2023-12-31	-1.96
2023-09-30	-1.71
2023-06-30	-2.25
2023-03-31	-3.28
2022-12-31	-6.95
2022-09-30	-46.25
2022-06-30	2.91
2022-03-31	2.77
2021-12-31	1.11
2021-09-30	1.07
2021-06-30	15.20
2021-03-31	3.37
2020-12-31	1.23
2020-09-30	0.94
2020-06-30	-1.77
2020-03-31	-3.01
2019-12-31	-12.44
2019-09-30	-2.65
2019-06-30	-10.89
2019-03-31	15.53
2018-12-31	1.64
2018-09-30	0.80
2018-06-30	0.43
2018-03-31	0.32
2017-12-31	0.29
2017-09-30	0.14
2017-06-30	0.13
2017-03-31	0.26
2016-12-31	0.29
2016-09-30	0.36
2016-06-30	0.61
2016-03-31	0.51
2015-12-31	0.21
2015-09-30	0.00
2015-06-30	0.00
2015-03-31	0.00
2014-12-31	0.00
2014-09-30	0.00
2014-06-30	0.00
2014-03-31	0.00
2013-12-31	0.00
2013-09-30	0.00
2013-06-30	0.00
2013-03-31	0.00
2012-12-31	0.00
2012-09-30	0.00
2012-06-30	0.00
2012-03-31	0.00
2011-12-31	0.00
2011-09-30	0.01
2011-06-30	0.01
2011-03-31	0.00
2010-12-31	0.01
2010-09-30	0.00
2010-06-30	0.01
2010-03-31	0.01
2009-12-31	0.03
2009-09-30	0.01
2009-06-30	0.13
2009-03-31	0.35
2008-12-31	0.09
2008-09-30	0.10
2008-06-30	0.09
2008-03-31	0.09
2007-12-31	0.09
2007-09-30	0.09
2007-06-30	0.10
2007-03-31	0.10
2006-12-31	0.10
2006-09-30	0.12
2006-06-30	0.10
2006-03-31	0.09
2005-12-31	0.13
2005-09-30	0.12
2005-06-30	0.11
2005-03-31	0.10
2004-12-31	0.10
2004-09-30	0.08
2004-06-30	0.08
2004-03-31	-0.10
2003-12-31	-0.11
2003-09-30	0.00
2003-06-30	0.00
2003-03-31	0.00

DATE

DEBT TO EQUITY RATIO

2026-06-30

-7.32

2026-03-31

-1.56

2025-12-31

-1.95

2025-09-30

-2.30

2025-06-30

-2.33

2025-03-31

-2.97

2024-12-31

-5.83

2024-09-30

-56.76

2024-06-30

7.28

2024-03-31

-1.91

2023-12-31

-1.96

2023-09-30

-1.71

2023-06-30

-2.25

2023-03-31

-3.28

2022-12-31

-6.95

2022-09-30

-46.25

2022-06-30

2.91

2022-03-31

2.77

2021-12-31

1.11

2021-09-30

1.07

2021-06-30

15.20

2021-03-31

3.37

2020-12-31

1.23

2020-09-30

0.94

2020-06-30

-1.77

2020-03-31

-3.01

2019-12-31

-12.44

2019-09-30

-2.65

2019-06-30

-10.89

2019-03-31

15.53

2018-12-31

1.64

2018-09-30

0.80

2018-06-30

0.43

2018-03-31

0.32

2017-12-31

0.29

2017-09-30

0.14

2017-06-30

0.13

2017-03-31

0.26

2016-12-31

0.29

2016-09-30

0.36

2016-06-30

0.61

2016-03-31

0.51

2015-12-31

0.21

2015-09-30

0.00

2015-06-30

0.00

2015-03-31

0.00

2014-12-31

0.00

2014-09-30

0.00

2014-06-30

0.00

2014-03-31

0.00

2013-12-31

0.00

2013-09-30

0.00

2013-06-30

0.00

2013-03-31

0.00

2012-12-31

0.00

2012-09-30

0.00

2012-06-30

0.00

2012-03-31

0.00

2011-12-31

0.00

2011-09-30

0.01

2011-06-30

0.01

2011-03-31

0.00

2010-12-31

0.01

2010-09-30

0.00

2010-06-30

0.01

2010-03-31

0.01

2009-12-31

0.03

2009-09-30

0.01

2009-06-30

0.13

2009-03-31

0.35

2008-12-31

0.09

2008-09-30

0.10

2008-06-30

0.09

2008-03-31

0.09

2007-12-31

0.09

2007-09-30

0.09

2007-06-30

0.10

2007-03-31

0.10

2006-12-31

0.10

2006-09-30

0.12

2006-06-30

0.10

2006-03-31

0.09

2005-12-31

0.13

2005-09-30

0.12

2005-06-30

0.11

2005-03-31

0.10

2004-12-31

0.10

2004-09-30

0.08

2004-06-30

0.08

2004-03-31

-0.10

2003-12-31

-0.11

2003-09-30

0.00

2003-06-30

0.00

2003-03-31

0.00

Debt to Equity Ratio: -7.32

CYTK Debt to Equity Ratio

CYTK Average Debt to Equity Ratio Chart

CYTK Current vs Average Debt to Equity Ratio Chart

CYTK Debt to Equity Ratio Metrics

CYTK Competitors' Debt to Equity Ratio

Financial Health

Debt to Equity Ratio Formula & Definition

Debt to Equity Ratio FAQ

CYTK Debt to Equity Ratio History

Related Metrics